The need to look at antibiotic resistance from a health systems perspective

Upsala Journal of Medical Sciences

Volumn 119, Issue 2, 2014, Pages 117-124

  Tomson, Göran ^a   Vlad, Ioana ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Antibiotics; Antibiotics resistance; Health systems; Systems thinking

Indexed keywords

ANTIBIOTIC RESISTANCE; HEALTH CARE DELIVERY; HUMAN;

DELIVERY OF HEALTH CARE; DRUG RESISTANCE, MICROBIAL; HUMANS;

EID: 84900859522     PISSN: 03009734     EISSN: None     Source Type: Journal    
DOI: 10.3109/03009734.2014.902879     Document Type: Review

References (47)

1. Kaplan W, Laing R. Priority medicines for Europe and the world. Geneva: World Health Organization; 2004.
2. World Health Organization. Everybody's business-strengthening health systems to improve health outcomes: WHO's framework for action. Geneva: World Health Organization; 2007.
3. de Savigny D, Adam T. Systems thinking for health systems strengthening. Geneva: World Health Organization; 2009.
4. Marais B, Crawford J, Iredell J, Ward M, Simpson S, Gilbert L, et al. One world, one health: beyond the Millennium Development Goals. Lancet. 2012;380:805-6.
5. Leibovici L, Paul M, Ezra O. Ethical dilemmas in antibiotic treatment. J Antimicrob Chemother. 2012;67:12-16.
6. Bigdeli M, Jacobs B, Tomson G, Laing R, Ghaffar A, Dujardin B, et al. Access to medicines from a health system perspective. Health Policy Plan. 2013;28:692-704.
7. Cars O, Hogberg LD, Murray M, Nordberg O, Sivaraman S, Lundborg CS, et al. Meeting the challenge of antibiotic resistance. BMJ. 2008;337:a1438.
8. Tomson G. The impact of global processes on health systems in Europe. Global Health Europe. 2010;2:1-47.
9. Goossens H, Ferech M, Vander Stichele R, Elseviers M, Group EP. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet. 2005;365:579-87.
10. Okeke IN, Laxminarayan R, Bhutta ZA, Duse AG, Jenkins P, O'Brien TF, et al. Antimicrobial resistance in developing countries. Part I: recent trends and current status. Lancet Infect Dis. 2005;5:481-93.
11. Newton PN, Green MD, Fernández FM, Day NPJ, White NJ. Counterfeit anti-infective drugs. Lancet Infect Dis. 2006;6:602-13.
12. Planta MB. The role of poverty in antimicrobial resistance. J Am Board Fam Med. 2007;20:533-9.
13. So AD, Ruiz-Esparza Q, Gupta N, Cars O. 3Rs for innovating novel antibiotics: sharing resources, risks, and rewards. BMJ. 2012;344:e1782.
14. Laxminarayan R, Heymann DL. Challenges of drug resistance in the developing world. BMJ. 2012;344:e1567.
15. Zaidi AK, Huskins WC, Thaver D, Bhutta ZA, Abbas Z, Goldmann DA. Hospital-acquired neonatal infections in developing countries. Lancet. 2005;365:1175-88.
16. Allegranzi B, Bagheri Nejad S, Combescure C, Graafmans W, Attar H, Donaldson L, et al. Burden of endemic health-careassociated infection in developing countries: systematic review and meta-analysis. Lancet. 2011;377:228-41.
17. Smith R, Coast J. The true cost of antimicrobial resistance. BMJ. 2013;346:f1493.
18. Okeke IN, Klugman KP, Bhutta ZA, Duse AG, Jenkins P, O'Brien TF, et al. Antimicrobial resistance in developing countries. Part II: strategies for containment. Lancet Infect Dis. 2005;5:568-80.
19. Ashley EA, Lubell Y, White NJ, Turner P. Antimicrobial susceptibility of bacterial isolates from community acquired infections in Sub-Saharan Africa and Asian low and middle income countries. Trop Med Int Health. 2011;16:1167-79.
20. Radyowijati A, Haak H. Improving antibiotic use in lowincome countries: an overview of evidence on determinants. Soc Sci Med. 2003;57:733-44.
21. Davey P, Brown E, Charani E, Fenelon L, Gould IM, Holmes A, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev. 2013;4:CD003543.
22. Laxminarayan R, Duse A, Wattal C, Zaidi AKM, Wertheim HFL, Sumpradit N, et al. Antibiotic resistance-the need for global solutions. Lancet Infect Dis. 2013;13: 1057-98.
23. Lim YW, Steinhoff M, Girosi F, Holtzman D, Campbell H, Boer R, et al. Reducing the global burden of acute lower respiratory infections in children: the contribution of new diagnostics. Nature. 2006;444:9-18.
24. Morgan DJ, Okeke IN, Laxminarayan R, Perencevich EN, Weisenberg S. Non-prescription antimicrobial use worldwide: a systematic review. Lancet Infect Dis. 2011;11:692-701.
25. Zarb P, Goossens H. Human use of antimicrobial agents. Rev Sci Tech. 2012;31:121-33.
26. Hawkings NJ, Butler CC, Wood F. Antibiotics in the community: a typology of user behaviours. Patient Educ Couns. 2008;73:146-52.
27. Nordberg P, Stålsby-Lundborg C, Tomson G. Consumers and providers - could they make better use of antibiotics? Int J Risk Safe Med. 2005;17:117-25.
28. Byarugaba DK. A view on antimicrobial resistance in developing countries and responsible risk factors. Int J Antimicrob Agents. 2004;24:105-10.
29. World Health Organization. Critically important antimicrobials for human medicine: categorization for the development of risk management strategies to contain antimicrobial resistance due to non-human antimicrobial use. Report of the Second WHO Expert Meeting Copenhagen: World Health Organization; 2007.
30. Bengtsson B, Greko C. Antibiotic resistance-consequences for animal health, welfare, and 3 food production. Upsala J Med Sci. 2014; [Epub ahead of print].
31. Larsson DGJ. Antibiotics in the environment. Upsala J Med Sci. 2014; [Epub ahead of print].
32. So AD, Gupta N, Brahmachari SK, Chopra I, Munos B, Nathan C, et al. Towards new business models for R&D for novel antibiotics. Drug Resist Updat. 2011;14:88-94.
33. Levin A, Kaddar M. Role of the private sector in the provision of immunization services in low- and middle-income countries. Health Policy Plan. 2011;26:i4-12.
34. Newton PN, Amin AA, Bird C, Passmore P, Dukes G, Tomson G, et al. The primacy of public health considerations in defining poor quality medicines. PLoS Med. 2011;8: e1001139.
35. Marshall BM, Levy SB. Food animals and antimicrobials: impacts on human health. Clin Microbiol Rev. 2011;24:718-33.
36. Grave K, Jensen VF, Odensvik K, Wierup M, Bangen M. Usage of veterinary therapeutic antimicrobials in Denmark, Norway and Sweden following termination of antimicrobial growth promoter use. Prev Vet Med. 2006;75:123-32.
37. Molstad S, Erntell M, Hanberger H, Melander E, Norman C, Skoog G, et al. Sustained reduction of antibiotic use and low bacterial resistance: 10-year follow-up of the Swedish Strama programme. Lancet Infect Dis. 2008;8: 125-32.
38. European Centre for Disease Prevention and Control. Antimicrobial resistance surveillance in Europe 2012. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Stockholm: ECDC; 2013.
39. World Health Organization Regional Office for Europe. Countries - Romania - Areas of Work. Available at http://www.euro.who.int/en/countries/romania/ areas-of-work. accessed 24 November 2013.
40. Wertheim HF, Chandna A, Vu PD, Pham CV, Nguyen PD, Lam YM, et al. Providing impetus, tools, and guidance to strengthen national capacity for antimicrobial stewardship in Viet Nam. PLoS Med. 2013;10:e1001429.
41. World Health Organization. The evolving threat of antimicrobial resistance: options for action. Geneva: World Health Organization; 2012.
42. Pshetizky Y, Naimer S, Shvartzman P. Acute otitis media-a brief explanation to parents and antibiotic use. Fam Pract. 2003;20:417-19.
43. Suffoletto B, Calabria J, Ross A, Callaway C, Yealy DM. A mobile phone text message program to measure oral antibiotic use and provide feedback on adherence to patients discharged from the emergency department. Acad Emerg Med. 2012;19:949-58.
44. Nglazi MD, Bekker LG, Wood R, Hussey GD, Wiysonge CS. Mobile phone text messaging for promoting adherence to anti-tuberculosis treatment: a systematic review protocol. Syst Rev. 2013;2:6.
45. Huttner B, Goossens H, Verheij T, Harbarth S; CHAMP Consortium. Characteristics and outcomes of public campaigns aimed at improving the use of antibiotics in outpatients in high-income countries. Lancet Infect Dis. 2010;10:17-31.
46. European Commission. Antimicrobial resistance. Special Eurobarometer 338. 2010. Available at http://ec.europa.eu/health/antimicrobial-resistance/docs/ ebs-338-en.pdf. accessed 23 November 2013.
47. Management Sciences for Health. Building local coalitions for containing drug resistance: a guide 2012. Available at http://www1.msh.org/projects/sps/ SPS-Documents/upload/AMR-guide-English-FINAL.pdf.accessed 24 November 2013.